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Letters to the Editorciates’ procedure results in a functional inter-
dependency between the right and left coro-
nary systems, whereas its concrete functional
consequences are unknown.
Nottin and coworkers3 later introduced
the use of an arterial conduit mainly in a
right-right CCB fashion. Although Nottin
and coworkers had never argued about the
physiologic aspects of CCB (just in view of
arterial conduit sparing), their approach
seems to be more physiologic, avoiding the
creation of functional imbrications between
the right and left coronary systems. The com-
mon point of the two aforementioned tech-
niques is nevertheless that the proximal anas-
tomosis takes off from a purely coronary
physiology, which is partly caused by the
coronary prompting effect of the sinus of
Valsalva.4,5
On the contrary, the inflow of the CCB
that is proposed by the authors takes off from
the midportion of the LAD. Because the mid-
LAD is subserved itself by the in situ left
internal thoracic artery, the authors’ CCB is
governed by an aorta-coronary physiology
rather than by the coronary physiology.
Consequently and in a physiologic point
of view, the CCB proposed by the authors is
just an indirect prolongation of in situ left
internal thoracic artery aorta-coronary by-
pass, which I suggest to call an anatomic
CCB. This latter procedure should not carry
the expected flow advantages of an authentic
physiologic CCB, such as the procedure of
Nottin and coworkers.3
In conclusion, I would congratulate Dr
Nežic´’s team for their innovation and espe-
cially their interest in CCB grafting and its
physiologic features.
Mathias H. Aazami, MD
Cardiac Surgery Department
Paris, France
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Reply to the Editor:
I read with great interest the comments of
Dr Aazami about the article my colleagues
and I recently published in The Journal of
Thoracic and Cardiovascular Surgery.1
We absolutely agree that the physio-
logic benefit (ie, diastolic blood flow closer
to physiologic norms) of coronary-coro-
nary bypass (CCB) grafting can be
achieved only when the origin and initial
segment of the targeted coronary artery are
free of atherosclerotic lesions. In such a
case we can use this region as a site of
proximal anastomosis in a CCB graft pro-
cedure, thus using the advantages of the
coronary prompting effect of sinuses of
Valsalva.2,3
We were able to use these advantages in
2 patients with multivessel coronary artery
disease, including single distal stenosis on
a large left anterior descending artery
(LAD) running well over the cardiac apex.
These distal LAD lesions were bypassed
with the CCB grafting technique by using a
short segment of the left internal thoracic
artery4 and a short segment of the radial
artery, respectively.5
There are very few articles in the liter-
ature discussing the CCB graft technique.
In our article,1 Biglioli and colleagues2
were cited to assure the readers that such an
approach had been tested and that normal
or natural (physiologic rather than ana-
tomic) flow could be expected in the distal
third of the bypassed LAD (supported, of
course, in this case with mid-LAD flow
from the in situ left internal thoracic ar-
tery). From our point of view, this CCB is
rather an imitation of the normal LAD vas-
cular bed (especially if anastomoses were
created in a terminoterminal fashion) than
prolongation of an in situ left internal tho-
racic artery graft.
In our opinion, neither the procedure of
Biglioli and colleagues2 nor that of Nottin
and coworkers6 is able to imitate pure
physiologic coronary flow. With the prox-
imal anastomosis of CCB grafting (in both
procedures) at the origin of the right coro-
nary artery (RCA; Figure 1 in Nottin and
scular Surgery ● November 2004coworkers6), there is at least an artificially
created new double orifice, causing blood
flow turbulence and thus affecting the
physiology of natural blood flow and dis-
tribution.
I would go even beyond the guidelines,
suggesting that CCB grafting is a possible
solution for low-grade stenosis (50%-60%)
of the RCA, of course in the presence of
significant multivessel coronary artery dis-
ease. It is very widely known that such an
RCA stenosis represents a real challenge
for the cardiac surgeon. All the grafts (ar-
terial and venous) that have been used have
had the worst patency rate in such condi-
tions.7,8 Perhaps CCB grafting (with the
RCA region free of lesions below the ori-
fice as a site of proximal anastomosis, even
in a terminoterminal fashion) would be a
good choice.
Finally, we have just refreshed the idea
of Dr Barboso and Dr Rusticali (they were
cited in our article), and therefore they de-
served Dr Aazami’s congratulations for the
innovation.
Duško Nežic´, MD, PhD, FETCS
Department of Cardiac Surgery
Dedinje Cardiovascular Institute
Belgrade, Serbia and Montenegro
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Thymic neuroendocrine carcinoma
(carcinoid): What if octreotide
scanning is negative?
To the Editor:
I was interested to read Filosso and col-
leagues’ recent description1 of a case of
thymic neuroendocrine carcinoma (carci-
noid) successfully treated with neoadju-
vant radiotherapy and chemotherapy and
the somatostatin (sst2) analog octreotide.
Filosso and colleagues1 stated, “Neu-
roendocrine tumors, including thymic tu-
mors, express sst2 at immunohistochem-
istry.” Other than octreotide scanning
and computed tomography or magnetic
resonance imaging (which were clearly
useful in their case), they did not discuss
other methods of localizing these tumors.
This gives the impression that all thymic
neuroendocrine carcinomas may be de-
tected with octreotide scanning. How-
ever, although others have also reported
octreotide scanning to be of use in de-
tecting thymic neuroendocrine tumors,2,3
this is not always the case. A recent case
series found none of 12 cases to have
positive results for sst2 receptors.4 Thus
if results of octreotide scanning are neg-
ative, other methods may be needed for
accurately localization of both the pri-
mary tumor and any metastases to treat
cases of thymic neuroendocrine carci-
noma as successfully as did Filosso and
colleagues.1 Other such methods that
may be useful are positron emission to-
mographic scanning with fluorodeoxy-
glucose labeled with fluorine 18 and
Tscanning with metaiodobenzylguanidine
labeled with iodine 123.4,5 In 2 cases
briefly reported from Guy’s Hospital,5 1
patient underwent octreotide scanning,
with negative results. However, positron
emission tomographic scanning localized
metastases, and radiolabeled metaiodo-
benzylguanidine was used to treat these
metastases.
Donald Whitaker, FRCS(ED)
Department of Cardiothoracic Surgery
Guy’s Hospital
London SE1 9RT, United Kingdom
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Reply to the Editor:
I thank Whitaker for his interest in our
recently published article.1 The message of
this article was the feasibility and the effi-
cacy of a multidisciplinary (chemoradio-
therapy, surgery, and biologic therapy)
he Journal of Thoracic and Cardiovasculartreatment for a giant and biologically ag-
gressive thymic neuroendocrine tumor.
The patient underwent preoperative oc-
treotide scintigraphy with positive results,
the in vivo demonstration of the somatosta-
tin receptors presence in the neoplastic tis-
sue. It is widely known that neuroendo-
crine tumors can have negative results of
octreotide scintigraphy; in my own experi-
ence, I have observed several bronchial
carcinoids (both typical and atypical) with
negative results of octreotide scintigraphy
and without somatostatin receptors in sur-
gical specimens. In some of these cases,
positron emission tomographic (PET) scan
results were positive. Probably these cases
represent a more aggressive variant of neu-
roendocrine neoplasm, but further reports
are needed to confirm this hypothesis.
I agree with Whitaker’s suggestion to
use PET scan when results of octreotide
scintigraphy are negative in the preopera-
tive patient assessment. One must consider,
however, that PET scan is not widely avail-
able in my country, and the cost of this
procedure is still high. Had the patient I
described had negative results of octreotide
scintigraphy, I definitely would have con-
sidered PET or metaiodobenzylguanidine
scanning.
Pier Luigi Filosso, MD
University of Torino Italy
San Giovanni Battista Hospital
Department of Thoracic Surgery
Via Genova 3, 10126 Torino, Italy
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